Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Moderna gets EU regulator nod for combined COVID, flu vaccine
06:09am, Friday, 27'th Feb 2026
Europe's medicines regulator on Friday recommended granting marketing authorisation to mCombriax, making Moderna's messenger RNA vaccine the world's first combined shot for people aged 50 and older ag
Moderna's Ups and Downs: Here's What You Need to Know Before Investing.
08:15am, Wednesday, 25'th Feb 2026
Moderna has faced good and bad times in recent years. Most recently, the FDA refused to review Moderna's flu candidate -- then reversed course.
Moderna Stock: How Far Can The Flu Shot Fly?
10:40am, Tuesday, 24'th Feb 2026
Moderna (MRNA) – a developer of mRNA-focused therapeutics and vaccines – has recorded a 6-day winning streak, accumulating gains of 25% during this time. The company's market capitalization has in
Here's Why I Wouldn't Touch Moderna With a 10‑Foot Pole Until Its Next Growth Engine Is Clear
09:00am, Monday, 23'rd Feb 2026
Moderna helped to rapidly create vaccines for COVID-19, leading to a financial windfall. But those vaccine sales have waned, and so has the company's top line.
Weekend Morning Brew: Amazon tops Walmart; Meta--Nvidia pact
07:37am, Saturday, 21'st Feb 2026
Weekly Market HighlightsWeekly performance was volatile at the extremes, with 876 stocks gaining more than 10% while 776 stocks declined by more than 10%.Marke
Billionaire Philippe Laffont Just Dumped CoreWeave and Opened a Position in a Stock That Soared Nearly 50% in January.
05:10am, Saturday, 21'st Feb 2026
Philippe Laffont bought shares of CoreWeave in the first quarter of last year and recently closed that position. The investor favors tech stocks and innovators.
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Cuts Stake in Moderna, Inc. $MRNA
04:08am, Saturday, 21'st Feb 2026
BNP PARIBAS ASSET MANAGEMENT Holding S.A. cut its holdings in shares of Moderna, Inc. (NASDAQ: MRNA) by 70.5% during the third quarter, according to the company in its most recent filing with the Secu
Market Today: Blue Owl payout, GDP miss, oil and EV moves
05:36pm, Friday, 20'th Feb 2026
Guru Stock PicksGeorge Soros has made the following transactions:Reduce in SPSB by 5.19%Sold out in MMYTAdd in AAMI by 61.3%New position in COINStock News Blue
First Look: Amazon tops Walmart; WBD--Netflix saga; oil up
07:38am, Friday, 20'th Feb 2026
Stock News Oil climbs on Iran risk: Crude headed for its first weekly gain in three weeks as tensions rose over potential U.S. strikes on Iran and possible Stra
Market Today: Amazon Overtakes Walmart; Blue Owl Rattles Credit; FDA Eyes Moderna Flu Shot
05:36pm, Thursday, 19'th Feb 2026
Guru Stock PicksLi Lu has made the following transactions:Sold out in SOCNew position in CROXStock News Stocks slip, private credit hit, oil climbs: Blue Owl Ca
BioNTech sues Moderna for patent infringement over COVID-19 shots
01:25pm, Thursday, 19'th Feb 2026
Biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna's COVID-19 vaccine mNexspike infringes a patent related to BioNTech and Pfizer's competing
Moderna Stock Jumps After FDA Reverses Course on Flu Shot
11:30am, Thursday, 19'th Feb 2026
MRNA stock rises 6% as the FDA agrees to review its flu vaccine filing after a surprise reversal, with a decision expected by Aug. 5, 2026.
First Look: Walmart beat, Meta trial, FDA eyes Moderna
07:39am, Thursday, 19'th Feb 2026
Stock News Zuckerberg testifies in youth harm case: Meta Platforms (META) CEO Mark Zuckerberg defended Instagram's design and policies in a Los Angeles trial ov
Moderna to Present at Upcoming Conferences in March 2026
07:00am, Thursday, 19'th Feb 2026
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / February 19, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 46th Annual Hea
Thrivent Financial for Lutherans Has $345,000 Stake in Moderna, Inc. $MRNA
04:52am, Thursday, 19'th Feb 2026
Thrivent Financial for Lutherans reduced its position in shares of Moderna, Inc. (NASDAQ: MRNA) by 85.7% in the undefined quarter, according to the company in its most recent 13F filing with the Secur
